Pascal Soriot – Charm

AstraZeneca listing move would be ‘memorable loss’ to London market

AstraZeneca CEO Pascal Soriot, pictured in London on June 28, 2023, reportedly wants to move the company’s stock listing from London to the United States. Justin Tallis | Afp | Getty Images Pressure is piling on London’s stock exchange, with reports that British pharma giant AstraZeneca may move its listing to the U.S. delivering yet…

AstraZeneca CEO considers moving company listing to US, the Times reports

Cs news2 days ago2 days ago01 mins

(Reuters) -AstraZeneca CEO Pascal Soriot is considering moving the company’s stock market listing to the U.S., the Times reported on Tuesday, citing multiple sources. Soriot has privately expressed a preference to shift the FTSE 100 company’s listing on multiple occasions and has also discussed relocating AstraZeneca’s domicile, the report said. The company declined to comment…